Evidence map›Paper›PMID 33467650›Full record

ReviewNutrients2021

Proanthocyanidins and Flavan-3-ols in the Prevention and Treatment of Periodontitis-Immunomodulatory Effects, Animal and Clinical Studies.

Izabela Nawrot-Hadzik, Adam Matkowski, Paweł Kubasiewicz-Ross, Jakub Hadzik

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Oral Wound Healing Potential ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Izabela Nawrot-HadzikDepartment of Pharmaceutical Biology and Botany, Wroclaw Medical University, 50556 Wroclaw, Poland.ORCID 0000-0002-5797-7336
Adam MatkowskiDepartment of Pharmaceutical Biology and Botany, Wroclaw Medical University, 50556 Wroclaw, Poland.
Paweł Kubasiewicz-RossDepartment of Dental Surgery, Wroclaw Medical University, 50425 Wroclaw, Poland.
Jakub HadzikDepartment of Dental Surgery, Wroclaw Medical University, 50425 Wroclaw, Poland.ORCID 0000-0002-2353-3198
Wroclaw Medical University · PL

Funding

Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu STM.B040.20.076Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu STM.D030.20.009
6 · The paper itself

Abstract

This paper continues the systematic review on proanthocyanidins and flavan-3-ols in the prevention and treatment of periodontal disease and covers the immunomodulatory effects, and animal- and clinical studies, while the other part discussed the direct antibacterial properties. Inflammation as a major response of the periodontal tissues attacked by pathogenic microbes can significantly exacerbate the condition. However, the bidirectional activity of phytochemicals that simultaneously inhibit bacterial proliferation and proinflammatory signaling can provide a substantial alleviation of both cause and symptoms. The modulatory effects on various aspects of inflammatory and overall immune response are covered, including confirmed and postulated mechanisms of action, structure activity relationships and molecular targets. Further, the clinical relevance of flavan-3-ols and available outcomes from clinical studies is analyzed and discussed. Among the numerous natural sources of flavan-3-ols and proanthocyanidins the most promising are, similarly to antibacterial properties, constituents of various foods, such as fruits of

Indexed as

AnimalsBiomarkersClinical Studies as TopicCytokinesDisease Models, AnimalDrug Evaluation, PreclinicalFlavonoidsHumansImmunomodulationInflammation MediatorsMatrix MetalloproteinasesOrgan SpecificityPeriodontitisProanthocyanidinsTreatment OutcomeBiomarkersCytokinesflavan-3-olFlavonoidsInflammation MediatorsMatrix MetalloproteinasesProanthocyanidinsCamellia sinensiscondensed tanninscranberryflavan-3-olsgingivitisgum diseaseimmunomodulatorynatural compoundsnatural substancesperiodontitispolyphenolsproanthocyanidins

Identifiers

PMID33467650
PMCPMC7830097
OpenAlexW3110011739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.